Cargando…
PP.48 Breakthrough SARS-CoV-2 Infection and COVID-19 Disease Severity in Lung Cancer Patients
Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9957599/ http://dx.doi.org/10.1016/j.jtho.2023.01.075 |
_version_ | 1784894863149367296 |
---|---|
author | Tavolacci, Sooyun Mack, Philip C. Gomez, Jorge E. Rohs, Nicholas Rodilla, Ananda M. De Miguel Perez, Diego Carreño, Juan Manuel Hsu, Chin-Yuan Cagan, Jazz Rolfo, Christian Moore, Amy Brody, Rachel I. King, Jennifer C. Gerber, David E. Henschke, Claudia I. Yankelevitz, David F. Minna, John D. Bunn, Paul García-Sastre, Adolfo Krammer, Florian Shyr, Yu Hirsch, Fred R. |
author_facet | Tavolacci, Sooyun Mack, Philip C. Gomez, Jorge E. Rohs, Nicholas Rodilla, Ananda M. De Miguel Perez, Diego Carreño, Juan Manuel Hsu, Chin-Yuan Cagan, Jazz Rolfo, Christian Moore, Amy Brody, Rachel I. King, Jennifer C. Gerber, David E. Henschke, Claudia I. Yankelevitz, David F. Minna, John D. Bunn, Paul García-Sastre, Adolfo Krammer, Florian Shyr, Yu Hirsch, Fred R. |
author_sort | Tavolacci, Sooyun |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9957599 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-99575992023-02-27 PP.48 Breakthrough SARS-CoV-2 Infection and COVID-19 Disease Severity in Lung Cancer Patients Tavolacci, Sooyun Mack, Philip C. Gomez, Jorge E. Rohs, Nicholas Rodilla, Ananda M. De Miguel Perez, Diego Carreño, Juan Manuel Hsu, Chin-Yuan Cagan, Jazz Rolfo, Christian Moore, Amy Brody, Rachel I. King, Jennifer C. Gerber, David E. Henschke, Claudia I. Yankelevitz, David F. Minna, John D. Bunn, Paul García-Sastre, Adolfo Krammer, Florian Shyr, Yu Hirsch, Fred R. J Thorac Oncol Article Published by Elsevier Inc. 2023-03 2023-02-25 /pmc/articles/PMC9957599/ http://dx.doi.org/10.1016/j.jtho.2023.01.075 Text en Copyright © 2023 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Tavolacci, Sooyun Mack, Philip C. Gomez, Jorge E. Rohs, Nicholas Rodilla, Ananda M. De Miguel Perez, Diego Carreño, Juan Manuel Hsu, Chin-Yuan Cagan, Jazz Rolfo, Christian Moore, Amy Brody, Rachel I. King, Jennifer C. Gerber, David E. Henschke, Claudia I. Yankelevitz, David F. Minna, John D. Bunn, Paul García-Sastre, Adolfo Krammer, Florian Shyr, Yu Hirsch, Fred R. PP.48 Breakthrough SARS-CoV-2 Infection and COVID-19 Disease Severity in Lung Cancer Patients |
title | PP.48 Breakthrough SARS-CoV-2 Infection and COVID-19 Disease Severity in Lung Cancer Patients |
title_full | PP.48 Breakthrough SARS-CoV-2 Infection and COVID-19 Disease Severity in Lung Cancer Patients |
title_fullStr | PP.48 Breakthrough SARS-CoV-2 Infection and COVID-19 Disease Severity in Lung Cancer Patients |
title_full_unstemmed | PP.48 Breakthrough SARS-CoV-2 Infection and COVID-19 Disease Severity in Lung Cancer Patients |
title_short | PP.48 Breakthrough SARS-CoV-2 Infection and COVID-19 Disease Severity in Lung Cancer Patients |
title_sort | pp.48 breakthrough sars-cov-2 infection and covid-19 disease severity in lung cancer patients |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9957599/ http://dx.doi.org/10.1016/j.jtho.2023.01.075 |
work_keys_str_mv | AT tavolaccisooyun pp48breakthroughsarscov2infectionandcovid19diseaseseverityinlungcancerpatients AT mackphilipc pp48breakthroughsarscov2infectionandcovid19diseaseseverityinlungcancerpatients AT gomezjorgee pp48breakthroughsarscov2infectionandcovid19diseaseseverityinlungcancerpatients AT rohsnicholas pp48breakthroughsarscov2infectionandcovid19diseaseseverityinlungcancerpatients AT rodillaanandam pp48breakthroughsarscov2infectionandcovid19diseaseseverityinlungcancerpatients AT demiguelperezdiego pp48breakthroughsarscov2infectionandcovid19diseaseseverityinlungcancerpatients AT carrenojuanmanuel pp48breakthroughsarscov2infectionandcovid19diseaseseverityinlungcancerpatients AT hsuchinyuan pp48breakthroughsarscov2infectionandcovid19diseaseseverityinlungcancerpatients AT caganjazz pp48breakthroughsarscov2infectionandcovid19diseaseseverityinlungcancerpatients AT rolfochristian pp48breakthroughsarscov2infectionandcovid19diseaseseverityinlungcancerpatients AT mooreamy pp48breakthroughsarscov2infectionandcovid19diseaseseverityinlungcancerpatients AT brodyracheli pp48breakthroughsarscov2infectionandcovid19diseaseseverityinlungcancerpatients AT kingjenniferc pp48breakthroughsarscov2infectionandcovid19diseaseseverityinlungcancerpatients AT gerberdavide pp48breakthroughsarscov2infectionandcovid19diseaseseverityinlungcancerpatients AT henschkeclaudiai pp48breakthroughsarscov2infectionandcovid19diseaseseverityinlungcancerpatients AT yankelevitzdavidf pp48breakthroughsarscov2infectionandcovid19diseaseseverityinlungcancerpatients AT minnajohnd pp48breakthroughsarscov2infectionandcovid19diseaseseverityinlungcancerpatients AT bunnpaul pp48breakthroughsarscov2infectionandcovid19diseaseseverityinlungcancerpatients AT garciasastreadolfo pp48breakthroughsarscov2infectionandcovid19diseaseseverityinlungcancerpatients AT krammerflorian pp48breakthroughsarscov2infectionandcovid19diseaseseverityinlungcancerpatients AT shyryu pp48breakthroughsarscov2infectionandcovid19diseaseseverityinlungcancerpatients AT hirschfredr pp48breakthroughsarscov2infectionandcovid19diseaseseverityinlungcancerpatients |